Treating addiction with deep brain stimulation: Ethical and legal considerations

C Lo, M Mane, JH Kim, M Berk, RR Sharp… - International Journal of …, 2023 - Elsevier
Background The use of neuromodulation in the treatment of psychiatric conditions is
controversial despite its lengthy history. This particularly applies to the use of invasive …

[HTML][HTML] Neural substrates of substance use disorders

MP Paulus - Current opinion in neurology, 2022 - journals.lww.com
Although progress has been made and there is both structural and functional imaging
evidence of an imbalance between brain structures involved in executive control and …

Clinical Correlates and Outcomes of Methamphetamine‐Associated Cardiovascular Diseases in Hospitalized Patients in California

L Curran, G Nah, GM Marcus, Z Tseng… - Journal of the …, 2022 - Am Heart Assoc
Background Methamphetamine misuse affects 27 million people worldwide and is
associated with cardiovascular disease (CVD); however, risk factors for CVD among users …

Methamphetamine alters nucleus accumbens neural activation to monetary loss in healthy young adults

NA Crane, H Molla, H de Wit - Psychopharmacology, 2023 - Springer
Rationale Stimulant drugs like methamphetamine (MA) activate brain reward circuitry, which
is linked to the development of problematic drug use. It is not clear how drugs like MA alter …

Influence of reconsolidation in maintenance of cocaine-associated contextual memories formed during adolescence or adulthood

ANH Charpentier, DI Olekanma, CT Valade… - Scientific Reports, 2023 - nature.com
Adolescents are at increased risk to develop substance use disorders and suffer from
relapse throughout life. Targeted weakening of drug-associated memories has been shown …

[HTML][HTML] A systematic review and meta-analysis of health, functional, and cognitive outcomes in young people who use methamphetamine

AA Guerin, T Bridson, HM Plapp, G Bedi - Neuroscience & Biobehavioral …, 2023 - Elsevier
Methamphetamine use typically starts in adolescence, and early onset is associated with
worse outcomes. Yet, health, functional, and cognitive outcomes associated with …

[HTML][HTML] Past and current drug repurposing clinical trials to treat cognition in methamphetamine use: a scoping review of pharmacotherapy candidates

MMS Peters, CHJ Park, A Turner, AA Guerin… - Addiction …, 2023 - Elsevier
Globally, methamphetamine is one of the most widely used illicit substances. Despite this,
there are no Food and Drug Administration (FDA)-approved pharmacotherapies for treating …

Predictors of abstinence maintenance after cocaine inpatient detoxification: A prospective study

M Poireau, V Clergue‐Duval, A Maillard… - … American Journal on …, 2024 - Wiley Online Library
Abstract Background and Objectives Cocaine is a highly addictive substance, and with no
approved medication for cocaine use disorder (CUD), leading to a heavy burden. Despite …

Trends in Self-reported and Biochemically Verified Cocaine and Methamphetamine Use Among Pregnant Individuals in Northern California, 2011-2019

KC Young-Wolff, NE Slama, V Sarovar… - JAMA Network …, 2022 - jamanetwork.com
Cocaine use and methamphetamine use during pregnancy have potential short-and long-
term health consequences. 1, 2 Rates of self-reported prenatal stimulant use have increased …

What is the risk of returning to the emergency department within 30 days for patients diagnosed with substance-induced psychosis?

D Barbic, M Whyte, G Sidhu, A Luongo… - Canadian Journal of …, 2022 - Springer
Objectives The primary objective of this study was to measure the risk of return Emergency
Department (ED) visits in patients presenting to the ED with a diagnosis of substance …